Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


Articles published in Transplantation

Retrieve available abstracts of 75 articles:
HTML format
Text format



Single Articles


    March 2017
  1. BHATI C, Idowu MO, Sanyal AJ, Rivera M, et al
    Long Term Outcomes in Patients Undergoing Liver Transplantation for Nonalcoholic Steatohepatitis Related Cirrhosis.
    Transplantation. 2017 Mar 15. doi: 10.1097/TP.0000000000001709.
    PubMed     Text format     Abstract available


  2. MURALI AR, Patil S, Phillips KT, Voigt M, et al
    Locoregional Therapy with Curative Intent versus Primary Liver Transplant for Hepatocellular Carcinoma: Systematic Review and Meta-analysis.
    Transplantation. 2017 Mar 10. doi: 10.1097/TP.0000000000001730.
    PubMed     Text format     Abstract available


  3. LAI Q, Feys E, Karam V, Adam R, et al
    Hepatic Epithelioid Hemangioendothelioma and Adult Liver Transplantation: Proposal for a Prognostic Score Based on the Analysis of the ELTR-ELITA Registry.
    Transplantation. 2017;101:555-564.
    PubMed     Text format     Abstract available


    January 2017
  4. BITTERMANN T, Goldberg DS, Bauer CM, Khungar V, et al
    Characterizing the risk of false-positive hepatocellular carcinoma in recipients transplanted with T2 MELD exceptions.
    Transplantation. 2017 Jan 25. doi: 10.1097/TP.0000000000001660.
    PubMed     Text format     Abstract available


  5. VINAIXA C, Strasser SI, Berenguer M
    DISEASE REVERSIBILITY IN PATIENTS WITH POSTHEPATITIS C CIRRHOSIS: IS THE POINT OF NO RETURN THE SAME BEFORE AND AFTER LIVER TRANSPLANTATION? A REVIEW.
    Transplantation. 2017 Jan 6. doi: 10.1097/TP.0000000000001633.
    PubMed     Text format     Abstract available


  6. RICH N, Tanriover B, Singal AG, Marrero JA, et al
    Outcomes of Simultaneous Liver Kidney Transplantation in Patients With Hepatocellular Carcinoma.
    Transplantation. 2017;101:e12-e19.
    PubMed     Text format     Abstract available


  7. LIU D, Chan AC, Fong DY, Lo CM, et al
    Evidence-Based Surveillance Imaging Schedule After Liver Transplantation for Hepatocellular Carcinoma Recurrence.
    Transplantation. 2017;101:107-111.
    PubMed     Text format     Abstract available


    December 2016
  8. KIM PT, Fernandez H, Gupta A, Saracino G, et al
    Low measured hepatic artery flow increases rate of biliary strictures in deceased donor liver transplantation: An age dependent phenomenon.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  9. LAI Q, Feys E, Karam V, Adam R, et al
    HEPATIC EPITHELIOID HEMANGIO-ENDOTHELIOMA AND ADULT LIVER TRANSPLANTATION: PROPOSAL FOR A PROGNOSTIC SCORE BASED ON THE ANALYSIS OF THE ELTR-ELITA REGISTRY.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  10. SALAZAR J, Saxena V, Kahn JG, Roberts JP, et al
    Cost-Effectiveness of Direct-Acting Anti-viral Treatment in Hepatitis C-infected Liver Transplant Candidates with Compensated Cirrhosis and Hepatocellular Carcinoma.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    November 2016
  11. MURALI AR, Romero-Marrero C, Miller C, Aucejo F, et al
    Predictors of Successful Downstaging of Hepatocellular Carcinoma Outside Milan Criteria.
    Transplantation. 2016;100:2391-2397.
    PubMed     Text format     Abstract available


  12. ZAHR ELDEEN F, Roll GR, Derosas C, Rao R, et al
    Preoperative Thromboelastography as a Sensitive Tool Predicting Those at Risk of Developing Early Hepatic Artery Thrombosis After Adult Liver Transplantation.
    Transplantation. 2016;100:2382-2390.
    PubMed     Text format     Abstract available


  13. KRAWCZYK M, Grat M, Adam R, Polak WG, et al
    Liver Transplantation for Hepatic Trauma: A Study From the European Liver Transplant Registry.
    Transplantation. 2016;100:2372-2381.
    PubMed     Text format     Abstract available


    August 2016
  14. POMPOSELLI JJ
    Hepatic Artery Thrombosis (HAT) After Liver Transplant: Not A Surgical Problem?
    Transplantation. 2016.
    PubMed     Text format    


  15. FURUICHI M, Fujiwara T, Fukuda A, Kasahara M, et al
    Fulminant hepatic failure as a risk factor for cytomegalovirus infection in children receiving preemptive therapy after living donor liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  16. TAPPER EB, Hughes MS, Buti M, Dufour JF, et al
    The optimal timing of hepatitis C therapy in transplant eligible patients with Child B and C Cirrhosis: A Cost-Effectiveness Analysis.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    July 2016
  17. GYOTEN K, Mizuno S, Kato H, Murata Y, et al
    A novel predictor of posttransplant portal hypertension in adult-to-adult living donor liver transplantation: increased estimated spleen/graft volume ratio.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  18. KROWKA MJ, Fallon MB, Kawut SM, Fuhrmann V, et al
    International Liver Transplant Society Practice Guidelines: Diagnosis and Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension.
    Transplantation. 2016;100:1440-52.
    PubMed     Text format     Abstract available


    June 2016
  19. HAN S, Yang JD, Sinn DH, Ko JS, et al
    Higher Bilirubin Levels of Healthy Living Liver Donors Are Associated With Lower Posttransplant Hepatocellular Carcinoma Recurrence.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  20. GEISSLER EK, Schnitzbauer AA, Schlitt HJ
    A Rebuttal Letter in Response to: Mammalian Target of Rapamycin Inhibitors Against Hepatocellular Carcinoma Recurrence After Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format    


  21. CHOLONGITAS E
    Mammalian Target of Rapamycin Inhibitors Against Hepatocellular Carcinoma Recurrence After Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format    


    April 2016
  22. DE CARLIS L, Lauterio A, De Carlis R, Ferla F, et al
    Donation After Cardiac Death Liver Transplantation After More Than 20 Minutes of Circulatory Arrest and Normothermic Regional Perfusion.
    Transplantation. 2016;100:e21-2.
    PubMed     Text format    


  23. KIMURA K, Shirabe K, Yoshizumi T, Takeishi K, et al
    Ischemia-Reperfusion Injury in Fatty Liver Is Mediated by Activated NADPH Oxidase 2 in Rats.
    Transplantation. 2016;100:791-800.
    PubMed     Text format     Abstract available


    March 2016
  24. SEDA-NETO J, Antunes da Fonseca E, Pugliese R, Candido HL, et al
    Twenty Years of Experience in Pediatric Living Donor Liver Transplantation: Focus on Hepatic Artery Reconstruction, Complications and Outcomes.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  25. KHORSANDI SE, Yip VS, Cortes M, Jassem W, et al
    Does Donation After Cardiac Death Utilization Adversely Effect Hepatocellular Cancer Survival?
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  26. FOSTER BJ, Dahhou M, Zhang X, Dharnidharka VR, et al
    High Risk of Liver Allograft Failure During Late Adolescence and Young Adulthood.
    Transplantation. 2016;100:577-84.
    PubMed     Text format     Abstract available


    February 2016
  27. WESTERKAMP AC, Karimian N, Matton AP, Mahboub P, et al
    Oxygenated Hypothermic Machine Perfusion After Static Cold Storage Improves Hepatobiliary Function of Extended Criteria Donor Livers.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  28. TOUSSAINT A, Weiss E, Khoy-Ear L, Janny S, et al
    Prognostic Value of Preoperative Brain Natriuretic Peptide Serum Levels in Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  29. ZHOU H, Zhu J, Yue S, Lu L, et al
    The Dichotomy of Endoplasmic Reticulum Stress Response in Liver Ischemia-Reperfusion Injury.
    Transplantation. 2016;100:365-72.
    PubMed     Text format     Abstract available


    January 2016
  30. POURCHER G, El-Kehdy H, Kanso F, Groyer-Picard MT, et al
    Volumetric Portal Embolization: A New Concept to Improve Liver Regeneration and Hepatocyte Engraftment.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  31. POMFRET EA
    Killing Two Birds With One Stone: Antineoplastic Immunosuppression.
    Transplantation. 2016;100:14-5.
    PubMed     Text format    


  32. LEUVENINK HG
    Warming Up--Not Only Essential for Athletes?
    Transplantation. 2016;100:10-1.
    PubMed     Text format    


  33. HOYER DP, Mathe Z, Gallinat A, Canbay AC, et al
    Controlled Oxygenated Rewarming of Cold Stored Livers Prior to Transplantation: First Clinical Application of a New Concept.
    Transplantation. 2016;100:147-52.
    PubMed     Text format     Abstract available


  34. VIJGEN S, Wyss C, Meylan P, Bisig B, et al
    Fatal Outcome of Multiple Clinical Presentations of Human Herpesvirus 8-related Disease After Solid Organ Transplantation.
    Transplantation. 2016;100:134-40.
    PubMed     Text format     Abstract available


    December 2015
  35. TANIMINE N, Tanaka Y, Abe T, Piao J, et al
    Functional Behavior of NKp46-Positive Intrahepatic Natural Killer Cells Against Hepatitis C Virus Reinfection After Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  36. DOYCHEVA I, Leise MD, Watt KD
    The Intestinal Microbiome and the Liver Transplant Recipient: What We Know and What We Need to Know.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    November 2015
  37. MAS V, Archer KJ, Maluf D
    The High-Risk Age Window After Pediatric Liver Transplantation: Modeling Allograft Loss Using Mathematical Tools.
    Transplantation. 2015.
    PubMed     Text format    


  38. GEISSLER EK, Schnitzbauer AA, Zulke C, Lamby PE, et al
    Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  39. MARIANTE-NETO G, Brandao AB
    Model for End-Stage Liver Disease: Is Sex-Based Creatinine Correction a Viable Strategy for Black Females?
    Transplantation. 2015;99:2337-40.
    PubMed     Text format     Abstract available


  40. NOBEL YR, Goldberg DS
    Variable Use of Model for End-Stage Liver Disease Exception Points in Patients With Neuroendocrine Tumors Metastatic to the Liver and Its Impact on Patient Outcomes.
    Transplantation. 2015;99:2341-6.
    PubMed     Text format     Abstract available


    October 2015
  41. SINGAL AK, Hasanin M, Kaif M, Wiesner R, et al
    Nonalcoholic Steatohepatitis is the Most Rapidly Growing Indication for Simultaneous Liver Kidney Transplantation in the United States.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    September 2015
  42. CHOI Y, Yi NJ, Ko JS, Moon JS, et al
    Reappraisal of the Role of Portacaval Shunting in the Growth of Patients With Glycogen Storage Disease Type I in the Era of Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  43. GIACOMONI A, Concone G, Di Sandro S, Lauterio A, et al
    Hepatocellular Carcinoma Progression While on Waiting List for Liver Transplantation.
    Transplantation. 2015;99:e155-e156.
    PubMed     Text format    


  44. MEHROTRA S, Kilambi V, Gilroy R, Ladner DP, et al
    The Authors' Reply.
    Transplantation. 2015;99:e160-1.
    PubMed     Text format    


  45. GENTRY SE, Segev DL, Kasiske BL, Mulligan DC, et al
    Robust Models Support Redistricting Liver Allocation to Reduce Geographic Disparity.
    Transplantation. 2015;99:e159-60.
    PubMed     Text format    


  46. MANGUS RS, Fridell JA, Kubal CA, Loeffler AL, et al
    Worse Long-term Patient Survival and Higher Cancer Rates in Liver Transplant Recipients With a History of Smoking.
    Transplantation. 2015;99:1862-1868.
    PubMed     Text format     Abstract available


  47. MANGUS RS, Lutz AJ, Fridell JA, Kubal CA, et al
    Minimal Improvement in Glomerular Filtration Rate in the First Year After Liver Transplantation.
    Transplantation. 2015;99:1855-1861.
    PubMed     Text format     Abstract available


  48. ERICZON BG, Wilczek HE, Larsson M, Wijayatunga P, et al
    Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative?
    Transplantation. 2015;99:1847-1854.
    PubMed     Text format     Abstract available


  49. PARAJULI S, Foley D, Djamali A, Mandelbrot D, et al
    Renal Function and Transplantation in Liver Disease.
    Transplantation. 2015;99:1756-64.
    PubMed     Text format     Abstract available


  50. IACOB S, Cicinnati VR, Lindemann M, Heinemann FM, et al
    Donor-Specific Anti-HLA Antibodies and Endothelial C4d Deposition-Association With Chronic Liver Allograft Failure.
    Transplantation. 2015;99:1869-75.
    PubMed     Text format     Abstract available


    August 2015
  51. GEHRAU RC, Mas VR, Dumur CI, Suh JL, et al
    Donor Hepatic Steatosis Induce Exacerbated Ischemia-Reperfusion Injury Through Activation of Innate Immune Response Molecular Pathways.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    June 2015
  52. GHABRIL M, Agarwal S, Lacerda M, Chalasani N, et al
    Portal Vein Thrombosis Is a Risk Factor for Poor Early Outcomes After Liver Transplantation: Analysis of Risk Factors and Outcomes for Portal Vein Thrombosis in Waitlisted Patients.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  53. ALHAMAD T, Uemura T, Lehman E, Spatz C, et al
    Utilization of donors after cardiac death organs for simultaneous liver and kidney transplantation.
    Transplantation. 2015;99:e40-1.
    PubMed     Text format    


  54. WADEI HM, Taner CB
    Simultaneous liver-kidney transplantation from donation after cardiac death donors: is there a better way to use these organs?
    Transplantation. 2015;99:e39.
    PubMed     Text format    


    May 2015
  55. CHENG Q, He SQ, Gao D, Lei B, et al
    Early Application of Auxiliary Partial Orthotopic Liver Transplantation in Murine Model of Wilson Disease.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  56. HAYASHI K, Uchida H, Takaoka C, Izawa Y, et al
    Discrepancy in Psychological Attitudes Toward Living Donor Liver Transplantation Between Recipients and Donors.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  57. LONGENECKER JC, Estrella MM, Segev DL, Atta MG, et al
    Patterns of Kidney Function Before and After Orthotopic Liver Transplant: Associations With Length of Hospital Stay, Progression to End-Stage Renal Disease, and Mortality.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  58. MOROSO V, van Cranenbroek B, Mancham S, Sideras K, et al
    Prominent HLA-G Expression in Liver Disease But Not After Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    April 2015
  59. BREUER C, Oh J, Nolkemper D, Achilles EG, et al
    Successful detoxification and liver transplantation in a severe poisoning with a chemical wood preservative containing chromium, copper, and arsenic.
    Transplantation. 2015;99:e29-30.
    PubMed     Text format    


    March 2015
  60. SCHIEFER J, Lebherz-Eichinger D, Erdoes G, Berlakovich G, et al
    Alterations of Endothelial Glycocalyx During Orthotopic Liver Transplantation in Patients With End-Stage Liver Disease.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  61. RANA A, Kaplan B, Riaz IB, Porubsky M, et al
    Geographic inequities in liver allograft supply and demand: does it affect patient outcomes?
    Transplantation. 2015;99:515-20.
    PubMed     Text format     Abstract available


  62. CEULEMANS LJ, De Hertogh G, Van Cromphaut S, Vermeire S, et al
    Nonsteroidal anti-inflammatory drug-induced intestinal graft loss 12 years after transplantation.
    Transplantation. 2015;99:e18-9.
    PubMed     Text format    


  63. HOON KIM S, Duke Lee S, Kyu-Kim Y, Park SJ, et al
    Living Donors Ages 60 or Older in Right Lobe Living Donor Liver Transplantation.
    Transplantation. 2015;99:e16-e17.
    PubMed     Text format    


    February 2015
  64. MANCIA C, Loustaud-Ratti V, Carrier P, Naudet F, et al
    Controlled Attenuation Parameter and Liver Stiffness Measurements for Steatosis Assessment in the Liver Transplant of Brain Dead Donors.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  65. MEHROTRA S, Kilambi V, Gilroy R, Ladner DP, et al
    Modeling the allocation system: principles for robust design before restructuring.
    Transplantation. 2015;99:278-81.
    PubMed     Text format     Abstract available


    January 2015
  66. DERCK JE, Thelen AE, Cron DC, Friedman JF, et al
    Quality of Life in Liver Transplant Candidates: Frailty Is a Better Indicator Than Severity of Liver Disease.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  67. OEZCELIK A, Dayangac M, Guler N, Yaprak O, et al
    Living Donor Liver Transplantation in Patients 70 Years or Older.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    December 2014
  68. DONNADIEU B, Amouyal F, Hoffart L, Matonti F, et al
    Central Retinal Vein Occlusion-Associated Tacrolimus After Liver Transplantation.
    Transplantation. 2014;98:e94-e95.
    PubMed     Text format    


  69. RAICHLIN E, Um JY, Duncan KF, Dumitru I, et al
    Combined Heart and Liver Transplantation Against Positive Cross-Match for Patient With Hypoplastic Left Heart Syndrome.
    Transplantation. 2014;98:e100-e102.
    PubMed     Text format    


    November 2014
  70. KENN K, Gloeckl R, Soennichsen A, Sczepanski B, et al
    Predictors of Success for Pulmonary Rehabilitation in Patients Awaiting Lung Transplantation.
    Transplantation. 2014.
    PubMed     Text format     Abstract available


    September 2014
  71. HMOUD B, Kuo YF, Wiesner RH, Singal AK, et al
    Outcomes of Liver Transplantation Alone After Listing for Simultaneous Kidney: Comparison to Simultaneous Liver Kidney Transplantation.
    Transplantation. 2014.
    PubMed     Text format     Abstract available


  72. KOLJONEN V, Fredrik A, Aki R, Heikki M, et al
    Self-Reported Alcohol Use and Depressive Symptoms After Liver Transplantation.
    Transplantation. 2014.
    PubMed     Text format     Abstract available


  73. ROCHA C, Perera MT, Roberts K, Bonney G, et al
    Outcomes After Liver Transplantation of Patients With Indo-Asian Ethnicity.
    Transplantation. 2014.
    PubMed     Text format     Abstract available


    August 2014
  74. CHANG Y, Gallon L, Shetty K, Chang Y, et al
    Simulation Modeling of the Impact of Proposed New Simultaneous Liver and Kidney Transplantation Policies.
    Transplantation. 2014.
    PubMed     Text format     Abstract available


    June 2014
  75. WADEI HM, Heckman MG, Rawal B, Taner CB, et al
    Renal Outcomes of Liver Transplant Recipients Who Had Pretransplant Kidney Biopsy.
    Transplantation. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: